TSS
RDHL

Two Sigma Securities’s Redhill Biopharma RDHL Stock Holding History

Two Sigma Securities’s Portfolio RDHL Stock Details RDHL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,019
Closed -$9.7K – 2246
2026
Q1 		$9.7K Buy
+13,019
New +$13.7K ﹤0.01% 1467
2024
Q3 		– Sell
-521
Closed -$4.83K – 3493
2024
Q2 		$4.83K Buy
521
+59
+13% +$655 ﹤0.01% 2861
2024
Q1 		$6.12K Buy
+462
New +$8.24K ﹤0.01% 2817
2023
Q4 		– Sell
-1,015
Closed -$12.9K – 3478
2023
Q3 		$12.9K Buy
1,015
+489
+93% +$12.8K ﹤0.01% 2648
2023
Q2 		$15.8K Buy
+526
New +$30.3K ﹤0.01% 2536
2022
Q3 		– Sell
-15
Closed -$13K – 3008
2022
Q2 		$13K Sell
15
-10
-40% -$13.7K ﹤0.01% 2019
2022
Q1 		$64K Buy
25
+4
+19% +$9.48K ﹤0.01% 1849
2021
Q4 		$55K Buy
+21
New +$84K ﹤0.01% 1263

Other funds holding RDHL

YAG
Yorkville Advisors Global Mountainside, New Jersey $86.2M AUM 41.28% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $32.7B AUM 35.71% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

Two Sigma Securities's RDHL Position: Q2 2026 in Review

Two Sigma Securities sold out of Redhill Biopharma (RDHL) in Q2 2026, closing a stake of 13,019 shares — an estimated $9.7K sold.

Two Sigma Securities first reported a position in RDHL in Q4 2021 and held it in 8 quarters. The position peaked at $64K in Q1 2022. 14 funds tracked by Wall St. Rank hold RDHL as of Q2 2026.

  • Two Sigma Securities reported no remaining Redhill Biopharma position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 13,019 Redhill Biopharma shares in Q2 2026, an estimated $9.7K.
  • Two Sigma Securities first reported a position in Redhill Biopharma in Q4 2021 and held it in 8 quarters.
  • Two Sigma Securities's Redhill Biopharma position peaked at $64K in Q1 2022.
  • 14 funds tracked by Wall St. Rank held Redhill Biopharma as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.